| PDF - Published Version (187kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-409940
- DOI to cite this document:
- 10.5283/epub.40994
Abstract
Background: Pulmonary invasive fungal infections (IFI) are well-recognized complications with high morbiditiy and mortality in patients with hematologic malignancies. Patients and Methods: Aerosolized liposomal amphotericin B (lipAmB) was evaluated as an antifungal prophylaxis in patients with an expected neutropenia of more than 10 days due to intensive chemotherapy or stem cell transplantation, ...

Owner only: item control page